The Holy Name Hospital Multiple Sclerosis Comprehensive Center will be the first hospital in the tri-state region to administer a breakthrough infusion therapy for MS patients that was licensed by the FDA earlier this week. The new biologic approach treats patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of symptom flare-ups or exacerbations of the disease. MS is a chronic, often disabling disease of the brain and spinal cord.
